Navigation Links
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Date:7/1/2008

FRANKLIN, Mass., July 1 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008. Echo's non-invasive Symphony tCGM System consists of its Prelude(TM) SkinPrep System, which incorporates patented and leading-edge skin permeation control technology, and wireless transmission and proprietary transdermal biosensor technologies. Echo's Symphony tCGM System is designed to provide both diabetes and hospital patients with a reliable, needle-free, easy-to-use, affordable and comfortable-to-wear continuous glucose monitoring device.

"Building on the momentum generated from our prior four positive pilot clinical studies, we are excited to have started our next pilot study in the important diabetes home use market. Our new Prelude Skin Prep System is a competitively unique component of our Symphony tCGM System, enabling our system to generate painless, needle-free, continuous glucose measurements. The primary purpose of this new study is to evaluate the performance of our Symphony tCGM System with Prelude as the new skin permeation element," stated Patrick T. Mooney, M.D., Echo's Chairman and Chief Executive Officer. "We are very excited about our significant development progress thus far, and we look forward to making additional progress with Symphony throughout 2008."

Echo's pilot clinical study will enroll ten (10) patients with diabetes (either Type 1 or Type 2) and will compare data obtained from its Symphony tCGM System with both the "gold standard" YSI Glucose Analyzer and a widely-used, commercially available "finger-stick" glucometer. The study will collect more than 900 data pairs to be used in the analyses. Reference glucose measurements will be mad
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
3. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
4. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
5. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
6. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
7. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Tess...croarray-based applications, announces the launch ...sting of the mutations that underlie human heredit...tise in microarray-based resequencing with novel n...ysis software enables screening for all targeted m...
(Date:11/9/2009)..., PALO ALTO, Calif., Nov. 9 Women... it has changed its name to Viveve as it prepares ...in select U.S. markets. ,, "Viveve is a name th...focus on women,s sexual health," said Kerry Pope, ...ists for the sole purpose of helping women restore...
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
(Date:11/9/2009)...why this is so, however , , MONDAY, No... with very dense breasts have a higher risk of can... shows. , Breast density has already been linke...er, and experts have suspected that very dense bre... of cancer recurrence at the site of the original ...
(Date:11/9/2009)...wire-USNewswire/ -- Speaker Nancy Pelosi released...e Affordable Health Care for America Act (H.R....duce Medicare Part D costs for people living with ...y a vote of 220 to 215: ,, "Effective drug tre...ife for thousands of Americans living with HIV/AID...
(Date:11/9/2009)...PRNewswire/ -- Abt Associates continues to broad...ergency management consulting and support services...the work of the Federal Emergency Management Agenc...onal Commission on Children and Disasters and the ...ATA). The value of the combined contracts is appr...
(Date:11/9/2009)...mental Procedure for Preteen Son - ,, PHILADE...ts of children with cancer, the hopeful news is th... for decades. Among the bad news -- treatments tha... Boys diagnosed with cancer who have reached puber... fertility: before undergoing cancer treatment, th...
(Date:11/9/2009)...wire-USNewswire/ -- The American Academy of Physic...00 clinically practicing physician assistants (PAs...S. House of Representatives for passing Saturday i...ble Health Care for America Act. ,, "We are esp...ately lower the cost of health care and greatly ex...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
...hildren that jumping for joy can hurt them, accord...ship Children's Hospital, Auckland, have called fo...rising number of children being injured while jump...ncrease in pre-Christmas trampoline sales, compare...
...bviously a difficult question to answer. //There i...ving stem cell research that this is a fast growin... medicine. Ideally a properly funded nation... to us because that is not an option for them: the...
... dietary regime which will include lots of green v...amount of calcium. This type of food guide is the ...od Guide has addressed this guide to all the Canad...rescribed by the Food Guide may affect the sale of...
...ng blood loss in patients undergoing cardiac surge...during five years following// the surgery, accordi...ed for use in high-risk patients needing coronary ...ave received aprotinin since 1985, principally dur...
...ive compounds that stimulate white blood cell prod...herapy are at an increased// risk of developing a ...stic syndrome, according to a new study in the Feb...be taken into consideration when making treatment ...
...es Network (SIGN) has published a set of guideline...00 cardiovascular complaints// like heart attacks ... aims to provide preventive treatment to about 500...ms to provide lifestyle advice. As per the g...
Other Medicine News:Health News:Drug Used in Coronary Artery Bypass Surgery may Increase Risk of Death 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 3Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
L-Hook Electrode
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
Medicine Products: